Honorary Fellow Recognition of Pharmacists in Critical Care

Clicks: 12
ID: 329463
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #235 of 247 articles by views in American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 247 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Honorary Fellow status is among the highest recognitions granted by professional societies and signifies sustained contributions to clinical practice, scholarship, leadership, and advancement of a specialty. This recognition was awarded to pharmacists soon after it became available to members of the Society of Critical Care Medicine. The percentage of pharmacists receiving honorary Fellow designation by the Society of Critical Care Medicine currently exceeds that of the organization's general membership. However, Fellow recognition of pharmacists in other critical care organizations demonstrates room for improvement.
Reference Key
openalex_W7214026351 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
Year 2026
DOI
10.1093/ajhp/zxag300
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.